APA

Langenberg M. H. G., van Herpen C. M. L., De Bono J., Schellens J. H. M., Unger C., Hoekman K., Blum H. E., Fiedler W., Drevs J., Le Maulf F., Fielding A., Robertson J. & Voest E. E. (20100121). Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Langenberg Marlies H G, van Herpen Carla M L, De Bono Johann, Schellens Jan H M, Unger Clemens, Hoekman Klaas, Blum Hubert E, Fiedler Walter, Drevs Joachim, Le Maulf Florence, Fielding Anitra, Robertson Jane and Voest Emile E. 20100121. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Langenberg M. H. G., van Herpen C. M. L., De Bono J., Schellens J. H. M., Unger C., Hoekman K., Blum H. E., Fiedler W., Drevs J., Le Maulf F., Fielding A., Robertson J. and Voest E. E. (20100121). Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Langenberg Marlies H G, van Herpen Carla M L, De Bono Johann, Schellens Jan H M, Unger Clemens, Hoekman Klaas, Blum Hubert E, Fiedler Walter, Drevs Joachim, Le Maulf Florence, Fielding Anitra, Robertson Jane and Voest Emile E. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20100121.